Bausch Health Cos Net Change in Investments - Total 2010-2025 | BHC

Bausch Health Cos net change in investments - total from 2010 to 2025. Net change in investments - total can be defined as the total change in long term and short term investments
Bausch Health Cos Annual Net Change in Investments - Total
(Millions of US $)
2024 $-134
2023 $-1,891
2022 $5
2021 $-4
2020 $4
2019 $-6
2018 $N/A
2017 $-5
2016 $16
2015 $18
2014 $-19
2013 $17
2012 $618
2011 $6
2010 $8
2009 $-3
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $1.681B $9.625B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.298B 6.98
Dr Reddy's Laboratories (RDY) India $12.071B 21.91
BridgeBio Pharma (BBIO) United States $6.397B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.850B 15.02
Amphastar Pharmaceuticals (AMPH) United States $1.178B 7.84
Taysha Gene Therapies (TSHA) United States $0.599B 0.00
Personalis (PSNL) United States $0.443B 0.00
Assembly Biosciences (ASMB) United States $0.105B 0.00
Sol-Gel Technologies (SLGL) Israel $0.021B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00